The current status of somatostatin receptors in malignant melanoma

William S. Fletcher, Sharon S. Lum, Robert W. Nance, Rodney F. Pommier, M. Sue O'Dorisio

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


On the basis that melanomas are of neural crest origin and might contain somatostatin receptors, the authors utilized 111In Pentetreotide (OctreoScan) to image 16 melanoma patients with known sites of disease. Twelve of 16 patients were positive with 38 percent imaging all sites. No lesion less than 1.5 cm imaged nor did one ocular and one amelanotic melanoma. Of the five described somatostatin receptors, OctreoScan binds only 2 and 5 suggesting that not all melanomas contain those receptors. It is concluded that melanomas contain somatostatin receptors and that this property might be used for imaging, tumor suppression with Octreotide, and/or as a target for Octreotide labelled with therapeutic agents such as immune complexes, chemotherapeutic agents or high energy radioisotopes.

Original languageEnglish (US)
Pages (from-to)561-563
Number of pages3
JournalYale Journal of Biology and Medicine
Issue number5-6
StatePublished - Sep 1997

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'The current status of somatostatin receptors in malignant melanoma'. Together they form a unique fingerprint.

Cite this